Original Research

Red cell allo- and autoimmunisation in transfused sickle cell and cancer patients in Kenyatta National Hospital, Nairobi, Kenya

Caroline Mangare, Amos Mbugua, Peter Maturi, Jamila Rajab, Rainer Blasczyk, Hans-Gert Heuft
African Journal of Laboratory Medicine | Vol 4, No 1 | a297 | DOI: https://doi.org/10.4102/ajlm.v4i1.297 | © 2015 Caroline Mangare, Amos Mbugua, Peter Maturi, Jamila Rajab, Rainer Blasczyk, Hans-Gert Heuft | This work is licensed under CC Attribution 4.0
Submitted: 28 January 2015 | Published: 25 September 2015

About the author(s)

Caroline Mangare, Jomo Kenyatta University of Agriculture and Technology, Nairobi, Kenya
Amos Mbugua, Jomo Kenyatta University of Agriculture and Technology, Nairobi, Kenya
Peter Maturi, Kenyatta National Hospital/ University of Nairobi, Department of Hematology and Blood Transfusion, Nairobi, Kenya
Jamila Rajab, Kenyatta National Hospital/ University of Nairobi, Department of Hematology and Blood Transfusion, Nairobi, Kenya
Rainer Blasczyk, Institute for Transfusion Medicine, Hannover Medical School, Hannover, Germany
Hans-Gert Heuft, Institute for Transfusion Medicine, Hannover Medical School, Hannover, Germany


Share this article

Bookmark and Share

Abstract

Background: Currently, no data are available on the prevalence of red blood cell (RBC) antibody formation amongst Kenyan patients with multiple transfusion needs, such as patients with sickle cell disease (SCD) or haematological malignancies (HM) and solid (SM) malignancies.

Objectives: We determined the prevalence and specificities of RBC alloantibodies and autoantibodies in two patient groups with recurrent transfusion demands at Kenyatta National Hospital, Nairobi, Kenya.

Method: Between February and August 2014, 300 samples from SCD, HM and SM patients were collected and screened for alloantibodies. Samples from 51 healthy blood donors were screened for irregular antibodies and phenotyped.

Results: Amongst the 228 patients with viable samples (SCD, n = 137; HM, n = 48; SM, n = 43), the median transfusion frequency was two to three events per group, 38 (16.7%) were RBC immunised and 32 (14.0%) had a positive direct antiglobulin test. We identified specific alloantibodies in six patients (2.6%). Four of these six were SCD patients (2.9%) who had specific RBC alloantibodies (anti-Cw, anti-M, anti-Cob, anti-S); amongst HM patients one had anti-K and one had anti-Lea. RBC autoantibody prevalence was 3.1% (7/228). Amongst the healthy blood donors, the Ror, ccD.ee and R2r, ccD.Ee phenotypes accounted for 82% of the Rhesus phenotypes and all were Kell negative.

Conclusion: The numbers of transfusions and the rates of RBC alloantibodies are low and the most important RBC alloantibody-inducing blood group antigens are relatively homogeneously distributed in this population. A general change in the Kenyatta National Hospital pre-transfusion test regimen is thus not necessary. The current transfusion practice should be reconsidered if transfusion frequencies increase in the future.


Keywords

No related keywords in the metadata.

Metrics

Total abstract views: 2405
Total article views: 4813

 

Crossref Citations

1. Red blood cell alloimmunization and minor red blood cell antigen phenotypes in transfused Ghanaian patients with sickle cell disease
Lilian A. Boateng, Andrew D. Campbell, Robertson D. Davenport, Alex Osei-Akoto, Sheri Hugan, Akwasi Asamoah, Henk Schonewille
Transfusion  vol: 59  issue: 6  first page: 2016  year: 2019  
doi: 10.1111/trf.15197